Trial Profile
Effect of brentuximab vedotin in patients with Hodgkin Lymphoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 14 Apr 2015 New trial record